Thor Medical ASA (LTS:0R6Y) Change In Receivables: kr-0.40 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0R6Y Thor Medical ASA LTS:0R6Y
27 GF Score
Price kr4.66
! 2 Warning Signs
View Full Analysis

What is Thor Medical ASA Change In Receivables?

Thor Medical ASA LTS:0R6Y -1.26% 27 Change In Receivables is kr-0.40 Mil as of Jun. 2026. GuruFocus rates LTS:0R6Y with a GF Score™ of 27/100. The stock has 2 warning signs investors should review.

Thor Medical ASA's change in receivables for the quarter that ended in Jun. 2026 was kr-0.20 Mil. It means Thor Medical ASA's Accounts Receivable increased by kr0.20 Mil from Dec. 2025 to Jun. 2026 .

Thor Medical ASA's change in receivables for the fiscal year that ended in Dec. 2025 was kr-0.30 Mil. It means Thor Medical ASA's Accounts Receivable increased by kr0.30 Mil from Dec. 2024 to Dec. 2025 .

Thor Medical ASA's Accounts Receivable for the quarter that ended in Jun. 2026 was kr0.50 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Thor Medical ASA's Days Sales Outstanding for the six months ended in Jun. 2026 was 101.39.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Thor Medical ASA's liquidation value for the six months ended in Jun. 2026 was kr-232.58 Mil.

Thor Medical ASA  (LTS:0R6Y) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Thor Medical ASA's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.5/0.9*91
=101.39

2. In Ben Graham's calculation of liquidation value, Thor Medical ASA's accounts receivable are only considered to be worth 75% of book value:

Thor Medical ASA's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=59.9-314+0.75 * 0.5+0.5 * 42.3
=-232.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thor Medical ASA Change In Receivables Related Terms

Thor Medical ASA Change In Receivables Historical Data

* Premium members only.

The historical data trend for Thor Medical ASA's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thor Medical ASA Change In Receivables Chart

Thor Medical ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -0.30

Thor Medical ASA Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.10 -0.20 -0.20
LTS:0R6Y
27GF Score
Thor Medical ASA LTS:0R6Y
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thor Medical ASA Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-0.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of kr-0.40 Mil mean?
Thor Medical ASA (LTS:0R6Y) has a Change In Receivables of kr-0.40 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Thor Medical ASA and its competitors.
Is Thor Medical ASA's Change In Receivables too high?
Thor Medical ASA's current Change In Receivables is kr-0.40 Mil. Overall, Thor Medical ASA has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Thor Medical ASA's Change In Receivables compare to VRTX and REGN?
Thor Medical ASA's Change In Receivables of kr-0.40 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Thor Medical ASA and its competitors. Thor Medical ASA's current Change In Receivables is kr-0.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thor Medical ASA stock overvalued right now?
Thor Medical ASA (LTS:0R6Y) has a current Change In Receivables of kr-0.40 Mil. The current Change In Receivables is kr-0.40 Mil. Thor Medical ASA's overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Thor Medical ASA (LTS:0R6Y), the current Change In Receivables is kr-0.40 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Thor Medical ASA Business Description

Other Exchanges TRMED:Norway8NN:Germany
Address Drammensveien 167, Oslo, NOR, 0277
Thor Medical ASA is a Norwegian radiopharmaceutical company that produces and supplies alpha-particle emitters used in targeted cancer therapy. Its core technology separates naturally occurring radioactive decay products from thorium, yielding lead-212 (Pb-212), a promising alpha emitter for radioligand therapies. The company's proprietary production process avoids irradiation and nuclear reactors, relying instead on thorium-232 decay chains. Thor Medical supplies these alpha-emitting materials to radiopharmaceutical and biotechnology companies that are developing targeted cancer treatments, positioning itself as an upstream supplier in the radiopharmaceutical value chain rather than a developer of finished drugs. Its operations and production activities are based in Norway, and it serves pharmaceutical partners internationally. Revenue is generated primarily through the supply of alpha-emitter isotopes and related production services to drug developers. The company is listed on the Oslo Børs.
27GF Score

Get the complete analysis for LTS:0R6Y

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr4.66
Price